Explore evidence

20 %In the study conducted in Paris, MPXV was undetectable in blood from about 20% of patients at diagnosis.

NigeriampoxHAL · Unilimdocument of 102 observations

1.4 unitlessMean HOMA-IR values were 1.4 ± 2.1 in obese diabetics.

Nigeriadiabète de type 2published 2026BMC research notesPubMeddocument of 6 observations

74.5 %At a predicted probability threshold of 0.745, the GDM prediction model had a specificity of 74.5%.

Nigeriagestational diabetes mellitus (GDM)published 2024BMC pregnancy and childbirthPubMeddocument of 2 observations

61.1 %Overall, 61.1% of people living with HIV on antiretroviral therapy in Nigeria were at risk for cardiovascular disease.

Nigeriamaladies cardiovasculairesobserved 2024published 2025AIDS research and therapyPubMeddocument of 7 observations

0.036 p_valueTP53 was significantly associated with breast cancer (five cases, zero controls; P = .036).

Nigeriacancer du seinpublished 2018Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument of 14 observations

59.6 %Invasive candidiasis accounted for 59.6% (n = 68) of the 114 reported IFI cases in the Nigerian paediatric population.

Nigeriainvasive candidiasisobserved 1964–2023published 2025Journal de mycologie medicalePubMeddocument of 17 observations

2.4 %Sickle Cell Disease was the third leading indirect cause of maternal mortality, accounting for 2.4% of cases.

Nigeriadrépanocytoseobserved 2007-2019published 2022BMC pregnancy and childbirthPubMeddocument of 10 observations

76.9 %The proportion of respondents with low 10-year risk of developing cardiovascular diseases was 76.9%.

Nigeriamaladies cardiovasculairespublished 2020BMC cardiovascular disordersPubMeddocument of 11 observations

10.8 %Cervical cancer screening prevalence among women aged 30–49 years in Nigeria was 10.8% in the South West region.

Nigeriacancer du col de l'utérusobserved 2023–24PubMeddocument of 3 observations

9.3 %Osteoarthritis was more frequent in subjects with diabetes mellitus (9.3%) than in non-diabetic controls (4.1%).

Nigeriadiabète (non précisé) · osteoarthritispublished 2020ReumatismoPubMeddocument of 8 observations

61 %At the 40% threshold, 61% of the poorest quartile of sickle cell disease patients experienced catastrophic expenditure.

Nigeriadrépanocytosepublished 2022PloS onePubMeddocument of 5 observations

44.9 %Ziziphus mauritiana at the high dose of 0.5 mg/ml caused a reduction in percentage of sickle red cells from 44.9% to 20.5% at 150 minutes.

Nigeriadrépanocytosepublished 2020West African journal of medicineeurope_pmcdocument of 3 observations

39 %Thirty-nine percent of Nigerian patients with non-metastatic T4 breast cancer were triple negative.

NigeriaT4 breast cancerobserved 2010 to 2016published 2021The oncologistPubMeddocument of 12 observations

17.8 %Thirty-eight (17.8%) of 213 prepandemic samples from Nigeria tested positive on the Euroimmun NCP IgG assay.

NigeriaCOVID-19published 2021Journal of clinical microbiologyPubMeddocument of 6 observations

71 %Among non-diabetic respondents in a cross-sectional survey, 71.0% of those who had raised blood sugar in the past were at high risk of developing type 2 diabetes.

Nigeriadiabète de type 2published 2021African health sciencesPubMeddocument of 10 observations

28.87 yearsThe mean age of the sickle cell patients was 28.87 ± 7.89 years.

Nigeriadrépanocytosepublished 2022West African journal of medicinePubMeddocument of 8 observations

0 p_valueProximity to the refinery was significantly associated with hypertension (P ≤ 0.0001).

Nigeriahypertension artériellepublished 2025Nigerian journal of clinical practicePubMeddocument of 6 observations

96.8 %96.8% of women in urban slums of Lagos, Nigeria had not heard about cervical cancer screening.

Nigeriacancer du col de l'utéruspublished 2022West African journal of medicinePubMeddocument of 13 observations

18.8 %The prevalence of diabetes mellitus among respondents was 18.8%.

Nigeriadiabète (non précisé)published 2020BMC cardiovascular disordersPubMeddocument of 11 observations

3.4 %The prevalence of newly diagnosed diabetes was 3.4% by fasting glucose test among participants surveyed in Ethiopia and Nigeria.

Éthiopie · Nigeriadiabète (non précisé)observed 2020 to 2021published 2025Journal of diabetesPubMeddocument of 8 observations

12 %In PVR D eyes, improved vision was seen in 12% of Vit.+RT cases.

Nigeriaproliferative vitreoretinopathyobserved 2005–2012published 2020Nigerian journal of clinical practicePubMeddocument of 11 observations

Clinical recovery from illness occurred in all children.

Nigeriapaludismepublished 2008Journal of infection and chemotherapy : official journal of the Japan Society of Chemothereurope_pmcdocument of 2 observations

90.3 %In 2019, 90.3% of pregnant women receiving antenatal care in Nigeria were screened for HIV.

NigeriaVIH/sidaobserved 2019published 2021International journal of STD & AIDSPubMeddocument of 10 observations

0 p-valueThe mutant pfmdr1Y86 allele was associated with in vivo chloroquine resistance (p=0.000042).

Nigeriapaludismepublished 2006Parasitology researcheurope_pmcdocument of 12 observations

Cervical cancer is the second leading cause of cancer morbidity and mortality among Nigerian women.

Nigeriacancer du col de l'utéruspublished 2023African journal of reproductive healthPubMeddocument of 4 observations